Public Employees Retirement System of Ohio acquired a new position in Avantor, Inc. (NYSE:AVTR - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 187,865 shares of the company's stock, valued at approximately $1,860,000.
Several other large investors have also modified their holdings of AVTR. Private Management Group Inc. increased its stake in Avantor by 50.4% in the fourth quarter. Private Management Group Inc. now owns 2,456,859 shares of the company's stock worth $28,156,000 after purchasing an additional 823,572 shares during the period. GSA Capital Partners LLP purchased a new stake in shares of Avantor during the second quarter valued at $800,000. Oppenheimer Asset Management Inc. bought a new position in shares of Avantor in the second quarter worth about $805,000. Assenagon Asset Management S.A. grew its stake in Avantor by 425.0% in the 2nd quarter. Assenagon Asset Management S.A. now owns 556,871 shares of the company's stock worth $5,513,000 after acquiring an additional 450,801 shares in the last quarter. Finally, Brickwood Asset Management LLP grew its stake in Avantor by 6,891.9% in the 4th quarter. Brickwood Asset Management LLP now owns 3,184,043 shares of the company's stock worth $36,489,000 after acquiring an additional 3,138,504 shares in the last quarter. Hedge funds and other institutional investors own 95.08% of the company's stock.
Wall Street Analyst Weigh In
AVTR has been the subject of several research analyst reports. Wall Street Zen raised shares of Avantor from a "hold" rating to a "buy" rating in a research note on Saturday, June 27th. TD Cowen reissued a "hold" rating on shares of Avantor in a research note on Wednesday, July 15th. Evercore set a $10.50 price objective on Avantor in a report on Monday, July 6th. Wells Fargo & Company lifted their target price on Avantor from $14.00 to $16.00 and gave the company an "overweight" rating in a research report on Thursday, July 30th. Finally, Sanford C. Bernstein started coverage on Avantor in a report on Friday, June 26th. They issued a "market perform" rating and a $10.50 target price for the company. Two equities research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Hold" and an average target price of $12.00.
View Our Latest Analysis on AVTR
Avantor Trading Down 0.1%
NYSE:AVTR opened at $14.96 on Monday. Avantor, Inc. has a one year low of $7.26 and a one year high of $15.93. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.18 and a current ratio of 1.78. The firm has a market cap of $10.12 billion, a P/E ratio of -17.81, a P/E/G ratio of 11.30 and a beta of 0.89. The firm has a 50-day simple moving average of $12.62 and a 200-day simple moving average of $9.94.
Avantor (NYSE:AVTR - Get Free Report) last released its quarterly earnings data on Wednesday, July 29th. The company reported $0.21 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.19 by $0.02. The firm had revenue of $1.69 billion for the quarter, compared to the consensus estimate of $1.61 billion. Avantor had a negative net margin of 8.81% and a positive return on equity of 9.92%. The company's quarterly revenue was up .5% on a year-over-year basis. During the same period last year, the firm earned $0.24 earnings per share. Avantor has set its FY 2026 guidance at 0.800-0.830 EPS. Equities analysts anticipate that Avantor, Inc. will post 0.81 EPS for the current fiscal year.
Avantor Company Profile
(
Free Report)
Avantor, Inc NYSE: AVTR is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.
Avantor's offerings are organized across two primary segments.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Avantor, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avantor wasn't on the list.
While Avantor currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Fall 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.